Ronel, J., Bührlen, B., Fischer, F., Boesecke, C., Kümmerle, T., Schneider, J., … The DUALIS Study Group. (2019, November 6). A switch to dolutegravir in combination with boosted darunavir is safe and effective in suppressed patients with HIV - a predefined psychosocial subanalysis of the DUALIS study. Poster presented at the 17th European AIDS Conference, Basel, Switzerland. Download abstract here